| abstract |
Disclosed in the present invention are a polysubstituted anilinopyrimidine derivative having a structure of general formula I, and a preparation method and application thereof, the derivative and a pharmaceutically acceptable salt or solvent compound thereof being a kinase CDK4, CDK6 and/or CDK 9 inhibitor, capable of more broadly being used in cancer treatment, and having great clinical application value. |